| Secondary |
| Atrial Fibrillation |
15.8% |
| Arthritis |
13.2% |
| Peripheral Vascular Disorder |
10.5% |
| Blood Pressure |
5.3% |
| Cardiac Pacemaker Insertion |
5.3% |
| Gout |
5.3% |
| Medical Diet |
5.3% |
| Musculoskeletal Pain |
5.3% |
| Oesophageal Disorder |
5.3% |
| Renal Disorder |
5.3% |
| Addison's Disease |
2.6% |
| Back Pain |
2.6% |
| Cystitis |
2.6% |
| Depression |
2.6% |
| Hyperlipidaemia |
2.6% |
| Multiple Sclerosis |
2.6% |
| Prophylaxis Urinary Tract Infection |
2.6% |
| Sepsis |
2.6% |
| Urinary Tract Infection |
2.6% |
|
| International Normalised Ratio Increased |
21.1% |
| Haemoptysis |
15.8% |
| Syncope |
10.5% |
| Urinary Tract Infection |
10.5% |
| Chromaturia |
5.3% |
| Hospitalisation |
5.3% |
| International Normalised Ratio Fluctuation |
5.3% |
| Loss Of Consciousness |
5.3% |
| Oedema Peripheral |
5.3% |
| Product Quality Issue |
5.3% |
| Renal Function Test Abnormal |
5.3% |
| Vomiting Projectile |
5.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
48.2% |
| Drug Use For Unknown Indication |
9.6% |
| Multiple Sclerosis |
4.4% |
| Osteoporosis |
4.4% |
| Hypertension |
4.3% |
| Pain |
3.0% |
| Rheumatoid Arthritis |
2.9% |
| Depression |
2.8% |
| Prophylaxis |
2.5% |
| Supplementation Therapy |
2.4% |
| Vitamin Supplementation |
2.1% |
| Gastrooesophageal Reflux Disease |
2.0% |
| Insomnia |
1.7% |
| Diabetes Mellitus |
1.6% |
| Urinary Tract Infection |
1.6% |
| Blood Cholesterol Increased |
1.6% |
| Crohn's Disease |
1.4% |
| Anxiety |
1.3% |
| Atrial Fibrillation |
1.1% |
| Cardiac Disorder |
1.0% |
|
| Urinary Tract Infection |
15.7% |
| Weight Increased |
9.3% |
| Vomiting |
8.9% |
| Pruritus |
7.6% |
| Flushing |
5.5% |
| Rash |
4.7% |
| Fall |
4.2% |
| Nausea |
4.2% |
| Pain |
4.2% |
| Weight Decreased |
4.2% |
| Injection Site Pain |
3.8% |
| Pulmonary Embolism |
3.8% |
| Drug Ineffective |
3.4% |
| Headache |
3.0% |
| Syncope |
3.0% |
| Ventricular Septal Defect |
3.0% |
| Visual Impairment |
3.0% |
| Wound |
3.0% |
| Wrong Technique In Drug Usage Process |
3.0% |
| Death |
2.5% |
|
| Interacting |
| Atrial Fibrillation |
80.0% |
| Urinary Tract Infection |
20.0% |
|
| International Normalised Ratio Increased |
62.5% |
| Food Interaction |
25.0% |
| Medication Error |
12.5% |
|
